Biotechnology Market Research Reports

• Collagen & Gelatin Market for Regenerative Medicine (by Source (Porcine, Bovine, Marine), Value and Volume Analysis, Application (Orthopedic, Wound Care, Cardiovascular)) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Environmental Monitoring Market by Sampling Method (Active, Continuous), Product (Sensors, Wearables, Indoor, Outdoor Monitors), Component (Temperature, Noise, Particulate, Gas), Application – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Oligonucleotide Synthesis Market by End User (Pharmaceutical, Hospital, Biotechnology), by Product (Drugs, Probe, Linkers, Adaptor, Equipment, Reagent), Type, Application (Research, PCR, DNA, RNAi, Therapeutic) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Single use Bioreactors Market by Product, Type of Molecule, Type of Cell, Type, Application, End User – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Gene Expression Analysis Market by Services (Consumables (DNA chips, Reagents), Instruments (NGS, PCR), Services (Gene Expression Profiling)), by Product, by End User (Biotech & Pharma Companies, Research Centers) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Stem Cell Assay Market by Product & Service (Kits, Instruments), Type (Purification, Viability, Identification), Cell Type (HSCs, Mesenchymal, iPSCs, hESCs), Application (Clinical Research, Regenerative Medicine), End User – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Cell Dissociation Market by Product (Enzymatic (Trypsin, Collagenase, Elastase) Non-enzymatic, DNase), Type (Tissue Dissociation), Tissue (Epithelial, Connective), End User (Research Institutes, Pharmaceutical) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Sterility Testing Market by Application (Medical Devices, Pharmaceutical & Biotechnology), Product (Kits and Reagents, Instruments, Services), Test (Direct Inoculation Sterility Testing, Membrane Filtration Sterility Testing) – 2023s to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Efficacy Testing Market by Product and Service (Services, Consumables), Application (Cosmetic & Personal Care Products, Pharmaceutical Manufacturing), Type (Disinfectant Efficacy Testing, Antimicrobial Efficacy Testing) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) – 2023s to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Injectable Drug Delivery Market by Patient Care Setting (Hospital, Home Care), Type (Formulation, Device), Therapeutic, Usage Pattern, Administration (Skin, Musculoskeletal), Immunization, Distribution Channel – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Cell Counting Market by Product (Instruments (Cell Counter, Spectrophotometer, Flow Cytometer, Hemocytometer, Hematology Analyzer), Consumables (Assay Kits, Reagent, Microplate)), End User (Hospital, Pharmaceutical, Research) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Genomics Market by Application (Precision Medicine, Diagnostic Application), Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), End User (Research Institute) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Cellular Health Screening/ Health Testing Market by Sample (Serum, Blood, Saliva, Urine), Collection Site (Hospital, Diagnostic Labs, Home, Office), Type (Single (Inflammation, Telomere, Oxidative Stress, Heavy Metal), Multitest), and Region – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Synthetic Biology Market by by Application (Renewable Energy, Tissue Regeneration, Biofuel, Food & Agriculture, Bioremediation), Tools (Synthetic Cells, Oligonucleotides, Enzymes), by Technology (Bioinformatics, Gene Synthesis) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Augmented Reality And Virtual Reality Market By Technology, By Offering, By Device Type, By Application, Geography and Forecast 2023-2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Cannabis Testing Market by Product & Software (GC, LC, Spectroscopy (MS, Atomic), Standards, Column, LIMS, Accessories), End User (Pharmaceutical, Lab, Research), Service (Pesticides, Potency, Genetic Testing, Heavy Metal) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• High Throughput Screening Market by Technology (Lab on a Chip, Cell-Based Assays, Bioinformatics), Application (Primary Screening, Target Identification, Toxicology), Product (Reagent, Instruments, Service, Software), End User – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Live Cell Imaging Market Application (Stem Cells, Cell Biology, Drug Discovery), by Product (Consumables, Instruments, Services), End User (Research, Institutes Pharmaceutical & Biotechnology Companies, ) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options
Page 5 of 10‹ Previous123456789Next ›Last »

The Biotechnology Industry is witnessing an increase in collaborative partnerships with a view to developing newer techniques. During its “green wave” period the industry produced a number of agricultural applications. During its “red wave”, there were a number of developments in the medical space to target disease prevention and management. In its “white wave”, industrial applications were at the forefront. A further rise in demand for therapeutics and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is expected to further fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact rendering growth driver. It is expected to encourage researchers and manufacturers to increase R&D initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalised medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.

Our reports provide application insights, technology insights, regional insights and competitive insights on biomaterials, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology. To know more about our offerings in the Biotechnology market analysis, contact us.

The Biotechnology Industry is witnessing an increase in collaborative partnerships with the primary view of developing newer and pathbreaking technology. The market is set to expand at 9.9 percent CAGR to hit USD 775 billion by 2024 mainly on account of increase in the incidence of chronic diseases such as diabetes and cancer, development of technology innovation and favorable government conditions. The ratio of chronic disease all around the globe is continuously increasing, which is analyzed to propel growth in the industry overall. According to recent data, the estimated number of people affected by the chronic disease will rise to 629 million by 2045. Approximately half of America’s population suffers from at least one chronic disease and this number is growing continuously. These statistics are expected to pave the way for opportunities in the biotechnology market.

The industry has experienced what is known as a ‘wave’ phenomenon. During its ‘green wave’ period the industry produced a number of agricultural applications. During its ‘red wave’, there were a number of developments in the medical space to target disease prevention and management. In its ‘white wave’, industrial applications were at the forefront. A further rise in demand for therapeutic and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is also expected to boost fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact-rendering growth driver. It is expected to encourage researchers and manufacturers to increase research and development initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalized medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.

Global Market Studies’ Biotechnology Market Research reports analysis provide application insights, technology insights, regional insights and competitive insights vis-a-vis the subsectors of biomaterials, biomanufacturing, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology, among others. Key competitor analysis includes that of Agilent Technologies, Amgen, Abbott Laboratories, Bio-Rad Laboratories, BioGen Medical Instruments, Danaher, Merck, F. Hoffmann-La Roche, Illumina, PerkinElmer, Thermo Fisher Scientific and Qiagen.

Contact us at Global Market Studies to know more about our offerings in the Biotechnology sector.